Heart failure hospitalization risk associated with use of two classes of oral antidiabetic medications: an observational, real-world analysis

BACKGROUND: Newer oral antidiabetic drug classes are expanding treatment options for type 2 diabetes mellitus (T2DM); however, concerns remain. The objective was to assess relative risk of heart failure hospitalization of sodium–glucose co-transporter-2 (SGLT2) and dipeptidyl peptidase-4 (DPP4) inhi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cardiovasc Diabetol
Päätekijät: Gautam, Santosh, Agiro, Abiy, Barron, John, Power, Thomas, Weisman, Harry, White, Jeff
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2017
Aiheet:
Original Investigation
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5535291/
https://ncbi.nlm.nih.gov/pubmed/28756774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-017-0575-x
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia